Guided Therapeutics (GTHP) Change in Accured Expenses (2011 - 2026)

Guided Therapeutics has reported Change in Accured Expenses for 15 years, with the latest figure at $832000.0 in Q4 2025.

• Quarterly Change in Accured Expenses rose 433.33% year-over-year to $832000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (up 150.09% YoY) and the FY2025 annual result came in at $1.4 million, up 150.09% from the prior year.
• Change in Accured Expenses rose to $832000.0 in Q4 2025 per GTHP's latest filing, from $204000.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $832000.0 in Q4 2025 and troughed at -$450000.0 in Q3 2021.
• A 5-year average of $110450.0 and a median of $75000.0 in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2021 and 2024: Change in Accured Expenses slumped 454.33% in 2021, then surged 2009.52% in 2024.
• Over 5 years, Change in Accured Expenses stood at $571000.0 in 2021, then plunged by 77.41% to $129000.0 in 2022, then surged by 34.11% to $173000.0 in 2023, then dropped by 9.83% to $156000.0 in 2024, then soared by 433.33% to $832000.0 in 2025.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $832000.0, $204000.0, and $221000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.